Table 2.
Analysis of the safety and efficacy of autologous skin tissue cells grafting. The values are presented as the quantity (percentage) or the means (SD), **p＜0.01 versus preoperative.
| Pre-operation | Postoperative 6 months | Postoperative 12 months | p | |
|---|---|---|---|---|
| SCAR score | 9.58 [1.33] | 3.9 [1.36] | 2.67 [1.21] | ＜0.01 |
| Satisfactory rate | 0 | 85.2% | 94.7% | ＜0.01 |
| Infection rate | 0 | 0 | 0 | |
| Necrosis rate | 0 | 0 | 0 | |
| Re-treatment | 128（100%） | 25（19.5%） | 6（4.69%） | ＜0.01 |
| Sunken | 76（59.4%） | 12（9.4%） | 3（2.3%） | ＜0.01 |
| Apophysis | 52（40.6%） | 8（6.3%） | 2（1.6%） | ＜0.01 |
| Pigmentation | 128（100%） | 0 | 0 | |
| Hypopigmentation | 0 | 128（100%） | 20（15.6%） |